SAPA-DC United States

NGO
Website:
Www.sapadc.org
Headquartner in China
Biotech/Pharma Category
Vince Deng
President 

Satyarx Pharma Innovations Private Limited India

Satya is an early-stage Oncology biotech focused on discovering small molecule NCEs, with novel targets against well-established Oncogenes, Tumor suppressors and Synthetic Lethal targets. Satya's team has over 50 years' combined discovery expertise, having worked on over 75 targets and delivered 15 clinical candidates
Website:
www.satyarx.com
Company Size (Fulltime employees)
Year of foundation
2019
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Mr Murthy Chavali
LinkedIn logo CEO 
Functionality

Seeds Capital Netherlands

-
Website:
-
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Co-investment
Headquartner in China
Dr. Shu Fen Ho
Senior investment manager 
Functionality

Selfit Medical Israel

Selfit is a digital therapy startup focusing on the aging population and brain and heart conditions.
The company has developed a therapist robot based on AI and neuroscience with focus on physical and cognitive health.
Headquartner in China
Mrs. Shahar Figelman
CEO 
Functionality

Servier China

.
Website:
www.Servier.com
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Assets based licensing in
Headquartner in China
Cynthia Wang
BD&Licensing Director 

SGTC United States

Stanford Genome Technology Center
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
technology development partnership
Headquartner in China
Your Research Tool and Service name
genomics
Dr. Weihong Xu
Director 

Shaanxi Kaisheng Capital Management Co.,Ltd China

Armoured hold the Tianyi Group layout of science and technology investment capital investment platform. Armoured capital in order to create long-term value for the purpose, committed to accelerate the transformation of scientific and technological industry and fall to the ground, accelerate the development of innovative enterprise, and industry potential industry and change. So far, has invested Zephyrm Biotechnologies, Milky Way motivation, CSTshen, companies such as the future and will continue to pay attention to the capitalization of the business process and industry, seek the change from a single financial investment to the strategy of diversifying investment.
Partnering Objectives
Headquartner in China
Ruiying Deng
Investment Director 

Shanghai Bourgeon China

Healthcare Consulting and Investment
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Richard Xie
Health Care Head 

Shanghai cell therapy group China

Founded in 2013. Focus on cell therapy
Website:
www.shcell.com
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
海霞 高
总监 

Shanghai Fenglin Biomedical Development Co. Ltd China

Fenglin Biomedical Center (BioFM) is an innovation platform based in Xuhui Shanghai, which functions as the China soft-landing gateway for oversea bio-medical companies. It provides working spaces in downtown area in a flexible manner and helps clients increase their business value with professional services and by leveraging innovative resources including academics, hospitals, industries and venture capitals in the region. Different from the traditional accelerators and incubators, BioFM aims to be a boutique and unique service provider especially for bio-medical entrepreneurs, doctors, and scientists, while helping overseas companies and start-ups to develop their business in China quicker and better

Company Size (Fulltime employees)
Please specify your partnering goal
Attract innovative biomedical startups and established companies into Shanghai Fenglin Life Sciences Park
Headquartner in China
Richard Tao
Mr / Project Manager 
Functionality